Structure-Function Relationships of Factor VIII Elucidated through Recombinant DNA Technology

References
1 Sadler JE, Davie EW. Hemophilia A, hemophilia B and von Willebrand’s disease. In: Nienhuis AW, Leder P, Majerus PW. (eds) The Molecular Basis of Blood Diseases. WB Saunders Co; 1987. pp 575-630
2 van Dieijen G, Tans G, Rosing J, Hemker HC. The role of phospholipid and factor VIII_ain the activation of bovine factor X. J Biol Chem 1981; 256: 3433-3441
3 Vehar GA, Keyt B, Eaton D, Rodriquez H, O’Brien DP, Rotblat F, Oppermann H, Keck R, Wood WI, Harkins RW, Tuddenham EG D, Lawn RM, Capon DJ. Structure of human factor VIII. Nature (London) 1984; 312: 337-342
4 Wood WT, Capon DJ, Simonsen CC, Eaton DL, Gitschier J, Keyt B, Seeburg PH, Smith DH, Hillingshead P, Wion KL, Delwart E, Tuddenham EG D, Vehar GA, Lawn RM. Expression of active human factor VIII from recombinant DNA clones. Nature (London) 1984; 312: 330-337
5 Toole JJ, Knopf JL, Wozney JM, Sultzman LA, Beucker J, Pittman DD, Kaufman RJ, Brown E, Shoemaker C, Orr EC, Amphlett GW, Foster WB, Coe ML, Knutson GJ, Fass DN, Hewick RM. Molecular cloning of a cDNA encoding human antihemophilic factor. Nature 1986; 312: 342-347
6 Poole S, Firtel RA, Lamar E, Rowekamp W. Sequence and expression of the Discoidin I gene family in dictyostelium discoideum. J Mol Biol 1981; 153: 273-289
7 Mann KG, Jenny RJ, Krishnaswamy S. Cofactor proteins in the assembly and expression of blood clotting enzyme complexes. Ann u Rev Biochem 1988; 57: 915-956
8 Kane WH, Davie EW. Blood coagulation factors V and VIII: Structural and functional similarities and their relationship to hemorrhagic and thrombotic disorders. Blood 1988; 71: 539-555
9 Bontempo FA, Lewis JH, Gorenc TJ, Spero JA, Ragni MV, Scott JP, Starzl TE. Liver transplantation in hemophilia A. Blood 1987; 69: 1721-1724
10 Zelechowska MG, van Mourik JA, Brodniewicz-Proba T. Ultrastructural localization of factor VIII procoagulant antigen in human liver hepatocytes. Nature 1985; 217: 729-730
11 Wion KL, Kelley D, Summerfield JA, Tuddenham EG D, Lawn RM. Distribution fo factor VIII mRNA and antigen in human liver and other tissues. Nature 1985; 317: 726-729
12 Kaufman RJ, Wasley LC, Dorner AJ. Synthesis, processing, and secretion of recombinant human factor VIII expressed in mammalian cells. J Biol Chem 1988; 263: 6352-6362
13 Munro S, Pelham HR B. An Hsp70-like protein in the ER: Identity with the 78 Kd glucose-regulated protein and immunoglobulin heavy chain binding protein. Cell 1986; 46: 291-300
14 Dorner AJ, Bole DG, Kaufman RJ. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J Cell Biol 1987; 105: 2665-2674
15 Tuddenham EG D, Lane RS, Rotblat F, Johnson AJ, Snape TJ, Middleton S, Kemoff PB A. Response to infusions of poly electrolyte fractionated hunian factor VIII concentrate in human hemophilia A and von Willebrand’s disease. Br J Haematol 1982; 52: 259-267
16 Weiss HJ, Sussman II, Hoyer LW. Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand’s disease J Clin Invest 1977; 60: 390-404
17 Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS. Purified human factor VIII procoagulant protein: Comparatiive hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci (USA) 1985; 82: 8752-8756
18 Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (= 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc Natl Acad Sci (USA) 1986; 83: 5939-5942
19 Eaton DL, Wood WI, Eaton D, Hass PE, Hollingshead P, Wion K, Mather J, Lawn RM, Vehar GA, Gorman C. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 1986; 25: 8342-8347
20 Kaufman RJ, Pittman DD, Wasley LC, Foster BW, Amphlett GW, Giles AR. Directed mutagenesis in the study of the requirements for factor VIII activity in vitro and in vivo. Thromb Haemostas 1987; 58: 537 (Abstr 1970)
21 Giles AR, Tinlin S, Greenwood R. A canine model of hemophilic (factor VIII:C deficiency) bleeding. Blood 1982; 60: 727-730
22 Francis RT, McDonagh J, Mann KG. Factor V is a substrate for the transamidase factor XHIa. J Biol Chem 1986; 261: 9787-9792
23 Eaton DL, Rodriguez HR, Vehar GA. Proteolytic processing of human factor VIII. Correlation of specific cleavages by thrombin, factor Xa, and activated protein C with activation and inactivation of factor VIII coagulant activity Biochemistry 1986; 25: 505-512
24 Fulcher CA, Roberts JR, Zimmerman TS. Thrombin proteolysis of purified factor VIII procoagulant protein: Correlation of activation with generation of a specific polypeptide. Blood 1983; 61: 807-811
25 Fay PJ, Anderson MT, Chavin SI, Marder VJ. The size of human factor VIII heterodimers and the effects produced by thrombin. Biochim Biophys Acta 1986; 871: 268-278
26 Rotblat F, O’Brien DP, O’Brien FJ, Goodall AH, Tuddenham EG D. Purification of human factor VIII:C and its characterization by Western blotting using monoclonal antibodies. Biochemistry 1985; 24: 4294-4300
27 Pittman DD, Kaufman RJ. Proteolytic requirements for thrombin activation of anti-hemophilic factor (factor VIII). Proc Natl Acad Sci (USA) 1988; 85: 2429-2433
28 Ware J, Toomey J, Fulcher C, Zimmerman TS, Stafford DW. Factor VIII:C antigenic determinants defined by recombinant DNA. Blood 1987; 70: 1440
29 Scandella D, deGaaf Mahoney S, Mattingly M, Roeder D, Timmons L, Fulcher CA. Epitope mapping of human factor VIII inhibitor antibodies by deletion analysis of factor VIII fragments expressed in Escherichia coli. Proc Natl Acad Sci (USA) 1988; 85: 6152-6156
30 Lollar P, Hill-Eubanks DC, Parker CG. Association of the factor VIII light chain with von Willebrand factor. J Biol Chem 1988; 263: 10451-10455
31 Gitschier J, Kogan S, Levinson B, Tuddenham EG D. Mutations of factor VIII cleavage sites in hemophilia A. Blood 1988; 72: 1022-1028
32 Hultin MB, Jesty J. The activation and inactivation of human factor VIII by thrombin: Effect of inhibitors of thrombin. Activation and inactivation of human factor VIII Blood 1981; 57: 476-482
33 Rick ME, Hoyer LW. Thrombin activation of factor VIII: the effect of inhibitors. Br J Haematol 1977; 36: 585-597
34 Fulcher CA, Gardiner JE, Griffin JH, Zimmerman TS. Proteolytic inactivation of human factor VIII procoagulant protein by activated protein C and its analogy with factor V. Blood 1984; 63: 486-489
35 Pittman DD, Kaufman RJ. Internal deletions of factor VIII identify potentially important peptide sequences for binding to von Willebrand factor. Blood 1987; 70: 392 a
36 Pittman DD, Wasley LC, Murray BL, Wang JH, Kaufman RJ. Analysis of structural requirements for factor VIII function using site-directed mutagenesis. Thromb Haemostas 1987; 58: 804 a
37 Huttner WB, Baeuerle PA. Protein sulfation on tyrosine. In: Modern Cell Biology. Birgit SatiriH. (ed) Alan R Liss; Inc NY, NY: 1988. 6 97-140
38 Foster PA, Fulcher CA, Houghten RA, Zimmerman TS. An Immunogenic region within residues Val¹⁶⁷⁰-Glu¹⁶⁸⁴ of the factor VIII light chain induces antibodies which inhibit binding of factor VIII to von Willebrand factor. J Biol Chem 1988; 263: 5230-5234
39 Fay PJ. Reconstitution of human factor VIII from isolated subunits. Arch Biochem Biophys 1988; 262: 525-553
40 Rick MF. Activation of factor VIII by factor IXa. Blood 1982; 60: 744-751
41 Fay PJ. Thrombin-activated factor VIIIa is composed of a noncovalent 73/51 kD dimer. Thromb Haemostas 1987; 58: 343 (Abstr 1241)
42 Eaton DL, Hass PE, Riddle L, Mather J, Wiebe M, Gregory T, Vehar GA. Characterization of recombinant human factor VIII. J Biol Chem 1987; 262: 3285-3290
43 Lollar P, Parker CG. Subunit structure of thrombin-activated porcine factor VIII. Biochemistry 1989; 28: 666-674
44 Nesheim ME, Pittman DD, Wang JH, Slonosky D, Giles AR, Kaufman RJ. The binding of ³⁵S-labeled recombinant factor VIII to activated and unactivated human platelets. J Biol Chem 1988; 263: 16467-16470
45 Lollar P, Knutson GJ, Fass DN. Stabilization of thrombin-activated porcine factor VIII; C by factor IXa and phospholipid. Blood 1984; 63: 1303-1308
46 Omar MN, Mann KG. Inactivation of factor Va by plasmin. J Biol Chem 1987; 262: 9750-9755